P103 Endovascular therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage: single-center experience in a high-volume neurovascular unit

Julian Schwarting, Carolin Albrecht, Dominik Trost, Isabel C. Hostettler, Martin Renz, Bernhard Meyer, Claus Zimmer, Jan S. Kirschke, Christian Maegerlein, Jannis Bodden, Charlotte Lingg, Arthur Wagner, Maria Wostrack, Tobias Boeckh‐BehrensAbstracts 2024 · DOI

This blog post summarizes the research abstract P103: Endovascular therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage, published in the Journal of NeuroInterventional Surgery (2024).

TL;DR

When a brain aneurysm ruptures, the "second hit" of arterial narrowing (vasospasm) often causes more damage than the initial bleed. This study demonstrates that endovascular intervention—physically or chemically reopening these vessels—is a safe and highly effective "rescue" therapy, providing clinical improvement in 71% of symptomatic patients who failed conservative treatment.

What Problem Does This Paper Address?

A subarachnoid hemorrhage (SAH), usually caused by a ruptured aneurysm, is a catastrophic medical event. However, the danger doesn't end once the aneurysm is secured. In the days following the bleed, patients often develop Cerebral Vasospasm (CVS), where the large arteries in the brain narrow significantly.

This narrowing leads to Delayed Cerebral Ischemia (DCI)—essentially a slow-motion stroke caused by lack of blood flow. While doctors typically try "conservative" management (like maintaining high blood pressure to force blood through narrowed gaps), these methods often fail. Endovascular treatments, such as injecting calcium antagonists directly into the artery or using a balloon to mechanically dilate the vessel, exist as options, but their overall impact on clinical outcomes has remained a subject of debate in the neurosurgical community.

Methods

The researchers conducted a retrospective, single-center cohort study at a high-volume neurovascular unit. They analyzed 310 patients who suffered an SAH and subsequently developed CVS.

The team used a standardized protocol to trigger intervention. A patient was considered for endovascular "rescue" if they met the criteria for severe vasospasm, defined as:

  • Radiographic evidence: Blood flow velocity >200 cm/sec measured via transcranial Doppler ultrasound.
  • Clinical evidence: New neurological deficits or a drop of at least 2 points on the Glasgow Coma Scale (GCS).

Interventions included the local intra-arterial application of calcium antagonists (to chemically relax the vessel) or mechanical dilatation (using a balloon or similar device to physically widen the focal stenosis).

Datasets

As this is a clinical outcome study, the "dataset" consists of the 310-patient monocentric cohort treated at the authors' institution. This represents a significant sample size for this specific condition, particularly coming from a single "high-volume" center, which reduces variability in surgical technique and post-operative care.

Key Insights and Ideas

  • The "Rescue" Threshold: Nearly 30% of patients with vasospasm eventually required endovascular intervention because conservative therapy wasn't enough. This highlights that vasospasm is frequently refractory to standard bedside care.
  • Visual vs. Functional Success: There is often a gap between "fixing the picture" (angiographic success) and "fixing the patient" (clinical success). In this study, 86% of patients looked better on the X-ray (angiography), while 71% actually showed clinical improvement. This suggests that while reopening the vessel is usually successful, the brain tissue may already be damaged in some cases.
  • Safety Profile: One of the biggest hurdles for endovascular intervention is the fear of procedural complications (like tearing an already fragile artery). A 4% complication rate in this study is notably low, supporting the argument that in experienced hands, the benefits of intervention outweigh the risks.
  • Standardization Matters: The authors emphasize that their success was "embedded in a standardized detection and medical management process." This suggests that the timing and criteria for intervention are just as important as the surgical technique itself.

Key Results

  • Intervention Rate: 29.7% (92/310) of patients underwent endovascular procedures.
  • Radiographic Success: 86% of treated patients showed improved blood flow on follow-up imaging.
  • Clinical Success: 71% of patients who were deteriorating symptomatically showed clinical improvement after the procedure.
  • Worsening/Complications: Only 18% of patients continued to decline despite treatment, and the periprocedural complication rate was a low 4%.

Limitations and Future Work

The authors acknowledge that this was a retrospective study, which can introduce selection bias. Because it was a single-center study, the results may reflect the specific expertise of that high-volume unit and might not be immediately reproducible in smaller centers with less specialized staff.

Future research would ideally involve multi-center prospective trials to further refine the "well-defined criteria" for when to move from conservative management to endovascular intervention. Additionally, long-term functional outcomes (months or years post-discharge) would provide a clearer picture of whether these "rescues" lead to a better quality of life or simply survival.

Summary updated

Abstract

<h3>Introduction</h3> Subarachnoid hemorrhage (SAH) frequently leads to cerebral vasospasms (CVS) of large cerebral arteries as part of delayed cerebral ischemia (DCI). Endovascular treatment of CVS by local intraarterial application of calcium antagonists or mechanical dilatation of focal stenoses has become an additional therapeutic option in selected cases; its relevance for clinical practice remains controversial. <h3>Aim of Study</h3> To examine the potential benefits of endovascular intervention for the treatment of CVS following SAH. <h3>Methods</h3> In a retrospective monocentric cohort study, we included 310 SAH patients developing CVS during the hospital stay and evaluated their clinical and radiographic outcomes. Severe vasospasm was defined by a mean velocity of &gt;200 cm/sec in transcranial Doppler ultrasound and/or occurrence of new neurological deficits and/or decrease of at least 2 points on the Glasgow Coma Scale (GCS), respectively. <h3>Results</h3> 92 patients (29.7%) underwent endovascular interventions due to persistent symptoms despite conservative therapy. Among endovascularly treated patients, 86% (n=79) improved in terms of angiographic results. 71% (n = 44) who underwent endovascular interventions due to symptomatic deterioration improved clinically. Clinical worsening occurred in 18% of cases (n=11). Periprocedural complications were observed in 4% (n=4). <h3>Conclusion</h3> Endovascular intervention emerges as a safe and effective therapy for individuals experiencing delayed ischemic neurologic deficits triggered by large-artery vasospasm following SAH. Embedded in a standardized detection and medical management process and coupled with well-defined criteria for endovascular interventions, it is an efficient preventative approach to enhance neurological outcomes after SAH. <h3>Disclosure of Interest</h3> no.
BibTeX
@inproceedings{schwarting2024p,
  author = {Julian Schwarting and Carolin Albrecht and Dominik Trost and Isabel C. Hostettler and Martin Renz and Bernhard Meyer and Claus Zimmer and Jan S. Kirschke and Christian Maegerlein and Jannis Bodden and Charlotte Lingg and Arthur Wagner and Maria Wostrack and Tobias Boeckh‐Behrens},
  title = {{P103 Endovascular therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage: single-center experience in a high-volume neurovascular unit}},
  booktitle = {Abstracts},
  year = {2024},
  doi = {10.1136/jnis-2024-esmint.139},
}
Figure